Delivery Order SPE2DR25D3012-SPE2DR26F4F2Z
- Not listed
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 16, 2026, for the supply of Nemluvio 30 mg pens, with a completion deadline of February 9, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,033.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for supply of Nemluvio 30 mg pens, with completion targeted for February 4, 2026. This is a non-set-aside, competitively awarded contract with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $5,787.60 delivery order on July 14, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $3,735.44 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens on November 14, 2025, with completion expected by December 8, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- On January 13, 2026, the Defense Logistics Agency awarded a $4,066.16 delivery order to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 4, 2026 and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,787.60 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for Nemluvio 30 mg pens, with an ultimate completion date of October 21, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,033.08 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of February 10, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting...
- This delivery order, valued at $6,099.24, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Nemluvio 30 mg pens to be delivered to Conshohocken, Pennsylvania. The contract was awarded on January 13, 2026, with an ultimate completion date of February 4, 2026. This is a competitively awarded contract with no set-aside designation, funded by the Defense Logistics Agency under its Medical Supply Chain operations. This delivery order represents a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4F2ZDelivery Order
The Defense Logistics Agency awarded a $6,099.24 delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 20, 2026, for Nemluvio 30 mg pens, with a completion deadline of February 10, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 through December 2026 and serves as the primary vehicle for supplying pharmaceutical products and medical commodities to military healthcare systems worldwide. Amerisourcebergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Defense Health Agency and Department of Defense healthcare systems. The parent company, Cencora, Inc., holds an additional significant Indefinite Delivery Contract with the DLA valued at up to $999,999,999.00 through December 31, 2031. Through these comprehensive contract vehicles, the company supplies an extensive portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 1/19/26 |